Diana N. Vikulova

Diana N. Vikulova

Auto-generated profile, based on publicly available information

Diana N. Vikulova

University of British Columbia

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 July 2019 in Journal of the American Heart Association
Verified
Journal Article
Open access
PDF file
DVDiana N. Vikulova
Diana N. Vikulova
MGMaja Grubisic
Maja Grubisic
YZYinshan Zhao
Yinshan Zhao
KLKelsey Lynch
Kelsey Lynch
KHKarin H. Humphries
Karin H. Humphries
LBLiam R. Brunham
Liam R. Brunham
Background: The incidence of atherosclerotic cardiovascular disease has declined in the past 2 decades. However, these benefits may not extend to young patients. The objective of this work was to assess temporal trends in the incidence, risk profiles, sex‐related differences, and outcomes in a contemporary population of young patients presenting with coronary artery disease ( CAD ) in British Columbia, Canada. Methods and Results: We used a provincial cardiac registry to identify young patients (men aged <50 years, women aged <55 years), with a first presentation of CAD between 2000 and 2016, who had either ≥50% stenosis of ≥1 coronary arteries on angiography or underwent coronary revascularization. A total of 12 519 patients (30% women) met our inclusion criteria. The incidence of CAD remained stable and was higher for men than women (46–53 versus 18–23 per 100 000). Of patients, 92% had at least one traditional cardiovascular risk factor and 67% had multiple risk factors. The prevalence of diabetes mellitus, obesity, and hypertension increased during the study period and was higher for women. Women had fewer emergent procedures and revascularizations. Mortality rates decreased by 31% between 2000 and 2007, then were stable for the remaining 9 years. Mortality was significantly higher for women aged <45 years compared with men. Conclusions: The incidence of premature CAD has not declined, and the prevalence of 3 major cardiovascular risk factors increased between 2000 and 2016. The risk burden and mortality rates were worse for women. These data have important implications for the design of strategies to prevent CAD in young adults.

1 June 2020 in American Journal of Preventive Cardiology
Verified
Journal Article
Open access
DVDiana N. Vikulova
Diana N. Vikulova
ISIlia S. Skorniakov
Ilia S. Skorniakov
BBBrendon Bitoiu
Brendon Bitoiu
CBChad Brown
Chad Brown
ETEmilie Theberge
Emilie Theberge
LBLiam R. Brunham
Liam R. Brunham
Despite advances in screening and prevention, rates of premature coronary artery disease (CAD) have been stagnant. The goals of this study were to investigate the barriers to early risk detection and preventive treatment in patients with premature CAD. In particular, we: 1) assessed the performance of the latest versions of major international guidelines in detection of risk of premature CAD and eligibility for preventive treatment; and, 2) investigated real-life utilization of primary prevention with lipid-lowering therapies in these patients. We included patients in the Study to Avoid cardioVascular Events in British Columbia (SAVE BC), an observational study of patients with premature (males ​≤ ​50 years, females ​≤ ​55 years) angiographically confirmed CAD. Eligibility for primary prevention and treatment received were assessed retrospectively based on information recorded prior to or at the index presentation with CAD. Of 417 patients (28.1% females) who met the criteria, 94.3% had at least one major cardiovascular risk factor. In the retrospective risk assessment, 41.7%, 61.4%, and 34.3% (p ​< ​0.001) of patients met criteria for initiation of statin therapy, and an additional 13.9%, 8.4%, and 46.8% may be considered for treatment using the American College of Cardiology/American Heart Association, Canadian Cardiovascular Society, and European Society of Cardiology guidelines, respectively. Only 17.1% of patients received statins and 11.0% achieved guideline-recommended lipid goals before presentation. Diabetes and elevated plasma lipid levels were positively associated with treatment initiation, while smoking was associated with non-treatment. The current versions of major guidelines fail to recognize many patients who develop premature CAD as being at risk. The vast majority of these patients, including patients who have guideline-directed indications, do not receive lipid-lowering therapy before presenting with CAD. Our findings highlight the need for more effective screening and prevention strategies for premature CAD.

1 March 2014 in Rheumatology Science and Practice
Verified
Journal Article
Closed access
PDF file
LELyudmila P Evstigneeva
Lyudmila P Evstigneeva
EKE V Kozhemyakina
E V Kozhemyakina
ENE V Negodaeva
E V Negodaeva
GGG A Gusel'Nikova
G A Gusel'Nikova
ABA A Belkin
A A Belkin
OLO M Lesnyak
O M Lesnyak
Переломы позвонков при остеопорозе (ОП) сопровождаются снижением качества жизни (КЖ) и функциональными ограничениями. Физические упражнения часто рекомендуются таким пациентам с целью уменьшения боли, улучшения КЖ и функционального состояния. Цель – оценить влияние физических упражнений на КЖ, функциональные показатели, равновесие у пациентов с остеопоретическими переломами позвонков. Материал и методы. В исследование включено 78 женщин с переломами позвонков и хронической болью в спине (40 в основной и 38 в контрольной группе). Средний возраст в основной группе составил 70,7±8,1 года, в контрольной – 67,6±7,0 года (p=0,35). Изучаемые показатели перед началом исследования статистически значимо не различались между группами. Занятия физическими упражнениями в основной группе проводились по 40 мин 2 раза в неделю в течение 12 мес. Пациентам контрольной группы было рекомендовано придерживаться физической активности, которая была до начала исследования. Оценка изучаемых показателей в начале исследования и через 12 мес проводилась с помощью опросника QUALEFFO-41, компьютерной системы диагностики нарушения равновесия и теста «Встань и иди». Результаты. Через 12 мес в основной группе получено статистически значимое улучшение КЖ, как по общему баллу (41,2) по сравнению с контролем (57,3; р<0,0001), так и по значениям всех доменов, а также показателей равновесия в тестах «Подъем из положения сидя» и «Приставной шаг». При проведении теста «Встань и иди» через 12 мес в основной группе отмечалось статистически значимое уменьшение времени выполнения теста с 12,1±3,8 до 10,8±2,5 с (р=0,028) и отсутствие динамики в контроле (11,1±3,4 и 11,1±2,8 с соответственно). Выводы. Физические упражнения улучшают КЖ, функциональную активность и равновесие у пациентов с остеопоретическими переломами позвонков.

17 May 2023 in medRxiv
Verified
Preprint
Open access
PDF file
ETEmilie T. Théberge
Emilie T. Théberge
DVDiana N. Vikulova
Diana N. Vikulova
SPSimon N. Pimstone
Simon N. Pimstone
LBLiam R. Brunham
Liam R. Brunham
KHKarin H Humphries
Karin H Humphries
TSTara L. Sedlak
Tara L. Sedlak
Background Heart disease is the leading cause of premature death for women in Canada. Ischemic heart disease (IHD) is categorized as myocardial infarction (MI) with no obstructive coronary artery disease (MINOCA), ischemia with no obstructive coronary arteries (INOCA), and atherosclerotic obstructive coronary artery disease (CAD) with MI (MI-CAD) or without MI (non-MI CAD). This study aims to study the prevalence of traditional and non-traditional IHD risk factors and their relationships with (M)INOCA compared to MI-CAD and non-MI CAD in young women. Methods This study investigated women who presented with premature (≤55 years old) vasomotor entities of (M)INOCA or obstructive CAD confirmed by coronary angiography, who are currently enrolled in either the Leslie Diamond Women’s Heart Health Clinic Registry (WHC) or the Study to Avoid cardioVascular Events in BC (SAVEBC). Univariable and multivariable regression models were applied to investigate associations of risk factors with odds of (M)INOCA, MI-CAD or non-MI CAD. Results A total of 254 women enrolled between 2015-2022 were analyzed: 77 INOCA and 37 MINOCA from the WHC and 66 with non-MI CAD and 74 MI-CAD from SAVEBC. Regression analyses demonstrated that migraines and preeclampsia/gestational hypertension were the most significant risk factors with higher likelihood to associate with premature (M)INOCA relative to obstructive CAD. Conversely, the presence of diabetes and a current or previous smoking history had the highest likelihood to associate with premature CAD. Conclusion There are significant differences in the risk factor profiles of patients with premature (M)INOCA compared to obstructive CAD.

19 July 2026 in International Journal of Stroke
Verified
Journal Article
Closed access
DVDiana N Vikulova
Diana N Vikulova
VDVanessa Dizonno
Vanessa Dizonno
LZLily Zhou
Lily Zhou
JGJohnathon Gorman
Johnathon Gorman
RLRonda Lun
Ronda Lun
TFThalia S Field
Thalia S Field
Background: Venous thrombosis and venous thromboembolism (VTE) are important causes and complications of stroke. They may complicate acute stroke as deep venous thrombosis or pulmonary embolism (DVT/PE), contribute causally to ischemic stroke through paradoxical embolism from a patent foramen ovale (PFO), or present directly as cerebral venous thrombosis (CVT). Despite shared pathophysiological features and overlapping antithrombotic strategies, these conditions are typically considered separately, fragmenting evidence and limiting the exchange of concepts. Purpose: We therefore convened experts across both stroke neurology and thrombosis medicine fields to examine these conditions under a unifying venous theme and define priorities for future clinical trials. Methods: Thirty-two stroke and thrombosis clinicians and researchers identified research priorities across three domains: prevention of VTE after stroke, secondary prevention after PFO-related stroke, and acute and long-term management of CVT. Structured discussions were guided by the PICO (Population, Intervention, Comparison, Outcome) framework, followed by a Delphi survey to establish consensus. Priority questions centered on the balance between thrombosis prevention and bleeding risk and the optimal timing, duration, and choice of DVT/PE prophylaxis after stroke; the optimal antithrombotic strategy for patients awaiting or forgoing PFO closure; and, for CVT, the role of endovascular therapy in severe disease and the optimal duration of secondary prevention (Graphical Abstract). Across domains, the group prioritized pragmatic and platform trial designs, integration with international registries to address the rarity of CVT, and patient-oriented outcomes that extend beyond functional recovery. Conclusions: By considering these venous conditions together and bridging stroke and thrombosis disciplines, this work defines priority questions to address persistent evidence gaps, harmonize practice, and improve patient-centered outcomes.

3 October 2023 in Canadian Journal of Cardiology
Verified
Journal Article
Closed access
NMN. Malhi
N. Malhi
MKM. Kang
M. Kang
KHK. Huang
K. Huang
DVD. Vikulova
D. Vikulova
SPS. Pimstone
S. Pimstone
LBL. Brunham
L. Brunham